Black Diamond Therapeutics, Inc. Annual Depreciation in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Black Diamond Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2018 to 2023.
  • Black Diamond Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $86K, a 29.5% decline year-over-year.
  • Black Diamond Therapeutics, Inc. annual Depreciation for 2023 was $437K, a 14% decline from 2022.
  • Black Diamond Therapeutics, Inc. annual Depreciation for 2022 was $508K, a 148% increase from 2021.
  • Black Diamond Therapeutics, Inc. annual Depreciation for 2021 was $205K, a 294% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $437K -$71K -14% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-12
2022 $508K +$303K +148% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-12
2021 $205K +$153K +294% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $52K +$5K +10.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
2019 $47K +$3K +6.82% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 $44K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.